Solace Lifesciences
Wilmington, US · Delaware corporation
Founders & leadership
CC
Christopher C GrossNamed on SEC filing
GH
Garrett HollowayNamed on SEC filing
JM
James M PooleNamed on SEC filing
DP
David PilznerNamed on SEC filing
SK
Stephen KujawaNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 1 of 2 rounds · 2015–2018
▶$5MofferedDec 2018 · Other Health CareRule 506(b)
▶$5MofferedDec 2018 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James M PooleExecutive Officer, Director
- Stephen KujawaDirector
- David PilznerDirector
- Christopher G GrossExecutive Officer, Director
- Garrett HollowayDirector
- Offering amount
- $5M
- Minimum investment
- $50K
- Sales commissions
- $350K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedDec 2017 · 43 investors · Other Health CareRule 506(b)
▶$1.6MraisedDec 2017 · 43 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher C GrossExecutive Officer, Director
- Garrett HollowayDirector
- James M PooleExecutive Officer, Director
- David PilznerDirector
- Stephen KujawaDirector
- Offering amount
- $4M
- Amount sold
- $1.6M
- Minimum investment
- $25K
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Solace Lifesciences raised?
- Solace Lifesciences has disclosed $1.6M raised across 1 of its 2 known rounds.
- Where is Solace Lifesciences headquartered?
- Solace Lifesciences is headquartered in Wilmington, US.